Pyrazolopyrimidine compounds and uses thereof
US11542265B2 · kind B2 · utility
6Cited by
45References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2021 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Apr 23, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.